In this study, we demonstrated that TP53 mutations are prevalent in GBM and that TP53 mutations inhibit lipid peroxidation and reduce ROS levels in tumor cells, leading to the suppression of ferroptosis. This evidence concerns the gene TP53 and glioblastoma.